Showing posts with label common cold. Show all posts
Showing posts with label common cold. Show all posts

Zinc for the common cold: the industry responds


In my recent articles about zinc treatments for the common cold (in March and May), I expressed skepticism that zinc has any effect on the duration of colds.

The maker of Cold-EEZE, ProPhase Labs (PRPH), sent me a detailed response from their Chairman and CEO, which I'm posting here for my readers. Because the document is rather long, I've only included a portion of it below, with my commentary interspersed.  The full text, with references, can be found here.  Now on to the response.

Response from the makers of Cold-EEZE
The objective of this document is to respond to your original article in Forbes titled “Zinc Versus Chicken Soup, Round Two.”

The following information will provide a clearer picture as to what the Common cold is and how it progresses in your body.  Also discussed is how certain zinc formulations are clinically proven to reduce the severity of cold symptoms and the duration of the common cold by nearly half. Finally, we provide some clarity as to why some zinc formulations are more effective than others, and thus, some studies on zinc formulations demonstrate significant efficacy while other studies fail to do so.

We would like to start by correcting some misinformation in your article. Contrary to your claim, ProPhase Labs, Inc. (former The Quigley Corp.) did not sponsor the two clinical studies supporting the effectiveness of Cold-EEZE zinc lozenges.  ProPhase Labs, Inc. only provided the zinc gluconate lozenges for these studies.

The first study at The Dartmouth College was sponsored by Godfrey Science & Design, Inc., Huntingdon Valley, PA and by a grant from the Rorer Pharmaceutical Corp., Fort Washington, PA. The second study conducted by Cleveland Institute was granted by the General Pediatrics Research Fund and the Departments of Infectious Diseases and General Pediatrics of the Cleveland Clinic Foundation.

[COMMENT: I didn't claim that at all.  I stated, correctly, that all 17 studies in a recent review article were funded by industry.  The review article lists the funding sources in Table 1.]

Another criticism in your article related to the fact that some of the clinical studies had been conducted 10 to 20 years ago and that the results from these studies were therefore no longer valid. This is simply not a valid conclusion. The science to conduct such studies, the metrics to measure the response, and the statistical tools utilized for analyzing the results has not been modified or changed significantly during this time.  One should bear in mind that there are plenty of drug products on the market today which are approved by FDA based on clinical studies conducted more than 20-30 years ago.

[COMMENT: I did not state that these studies were "no longer valid."  Here's what I wrote 
"… their website points to three studies from 10-20 years ago.  They conveniently ignore the more recent studies that showed far less (possibly no) benefit."  
As any good scientist knows, scientific conclusions that don't hold up under further examination must be revised or thrown out entirely.  The follow-up studies of zinc didn't support these early results.  This happens all the time in science, and what we usually do is conclude that the early results were incorrect.] 

The Common Cold and Zinc
For the past decenniums, scientists have studied the effect of Zinc on the common cold caused by the Rhinovirus and have tried to understand the science behind it. The exact mechanism of action of Zinc in the common cold has not been fully identified yet; however, there is strong scientific evidence, based on several ex-vivo and in-vitro studies, supporting the two main mechanism hypotheses:

  1. The zinc ion, based on its specific property and electrical charge, has an affinity for a specific intracellular adhesion molecule called ICAM-1 receptor present in the nasal epithelium cells. The Zinc ion has an ability to form a complex with the receptor and thereby prevent the binding of the Rhinovirus to nasal epithelial cells.  
  2. The Zinc ion has an ability to prevent the formation of viral capsid proteins and thereby inhibits the replication of several viruses, including Rhinovirus.  

There are several peer reviewed scientific publications which provide a better understanding regarding the effect of Zinc on the common cold caused by Rhinovirus and the possible mechanism of actions to inhibit the progress of Rhinovirus infection. 

[COMMENT: the makers of Cold-Eeze point to a list of 9 "peer reviewed" papers that they say support their point. Few of us (certainly not me) have time to read all these papers, but I did look at them briefly.  Two papers are in the journal Medical Hypotheses, which is not only not peer reviewed, but is well known as a trash bin full of crank theories without any scientific support or plausibility.  See the excellent discussion by Photon in the Darkness about why Medical Hypotheses is a bogus source.
Citing bogus sources is never a good idea.  However, some of the other cited articles are legitimate, and the most recent one, from 2009, does show that zinc is a plausible agent for inhibiting the cold virus.]

The different outcomes from different Zinc studies
The inconsistency in the clinical results between different studies may be explained by the fact that: (i) the type of virus causing the common cold may have varied in each study and; (ii) the type of zinc formulation that was studied also varied. Different formulations use different types of additives such as flavoring agents and sugars which are commonly used to help improve the palatability of the zinc ions.  In some formulations, these additives form highly bound complexes with the zinc ions.  This results in poor ionic zinc availability.  Given the link between ionic zinc availability and prevention of cold virus replication, it is only logical that decreased ionic Zinc availability may lead to decreased efficacy observed in some particular clinical studies. Effective delivery of the Zinc ions in the oral cavity is critical to the success of zinc formulations reducing the duration of the common cold caused by rhinovirus. There are many forms of Zinc supplements which do not release the Zinc ions in the oral cavity. This is likely to be a major reason for the inconsistent results in some zinc studies.

[COMMENT: This is what is known as "special pleading", a common logical fallacy.  The many studies showing no effect are a big problem for zinc.  It just doesn't seem to work, and no amount of special pleading will change that.]

Based on the strong, statistically significant results obtained from the two double blinded, randomized, placebo controlled studies conducted by Cleveland Institute and The Dartmouth College, we are convinced that our Cold-EEZE product releases and effectively delivers the right amount of Zinc ions in the oral cavity to fight the Common Cold caused by rhinoviruses.  Furthermore, two other studies were conducted by the Heritage School in which teenage students were provided with one Cold-EEZE lozenge daily.  The reduction in the number of instances of upper respiratory infections was dramatic.  Moreover, for those students who did catch a cold, the duration was reduced significantly relative to the prior year.  Unfortunately, these were not placebo controlled studies so our technical conclusions are a bit more limited but the results are highly convincing and supportive of the other two statistically significant studies that we refer to.

[COMMENT: These are the older studies that have not held up upon further study.  The conclusions might be "highly convincing" to the makers of Cold-Eeze, but not to me.]

Finally, we include an insert in every package of Cold-EEZE, asking consumers for feedback.  Well over 90% of consumer feedback is directly positive toward efficacy and incredibly, only approximately 1% is negative regarding efficacy.  (The rest of the consumer feedback primarily relates to packaging and flavor comments and suggestions.)  These real life results in the field powerfully confirm the supportive clinical studies.

[COMMENT: Do you really believe that feedback from your own biased sample of consumers, who already bought your product on the assumption that it would work, is confirmatory evidence?  Sorry, but this claim gets a failing grade.]

Conclusions
An understanding of the different zinc formulations including their zinc ion availability and delivery is critical to drawing the appropriate conclusions with regard to zinc efficacy. Our intention in this response has not been to undermine the nutritional value of chicken soup which most probably has a complimentary function in shortening the duration of the common cold.

[COMMENT: We agree on chicken soup!]

Zinc still doesn't work very well for colds


Cold cure manufacturers continue to push zinc as a cure, despite the lack of evidence.  Today, the Washington Post reported, not for the first time, that taking zinc will shorten the duration a cold by three days in adults.  Sounds pretty good!  Only it's wrong.

The Post reporter apparently didn't really get past the abstract for the new study, which isn't actually a study at all, but just a review of 17 other studies.  The review appeared on May 8 in the Canadian Medical Association Journal.

ALL of the studies were funded by the companies that make zinc supplements, mostly large pharmaceutical companies.  (Big Pharma or Big Supp, they are often the same companies.)  Here's a partial list of the sponsors: Warner Lambert, McNeil Consumer Products, Weider Nutrition, Truett Laboratories, Bristol Myers, Berko Ilac, and Quigley.  Not that there's anything wrong with that!

One problem with the Washington Post summary is that the benefit wasn't really three days, even if you believe the results.  Although the study looked at 17 trials, the core analysis only used eight of them, all of which used patients with naturally acquired colds.  The average benefit was 1.6 days, not 3 days, and it was highly variable.  Reuters and Fox reported the story more accurately as "one and a half days" and pointed out that the effect was just over two and a half days in adults.

Somehow, though, the benefit disappeared in children.  Could this be because children don't care so much about telling the investigators what they want to hear?

And what about those trials that didn't use naturally occurring colds.  As I pointed out in a recent blog post, if you look at only the studies where the researchers intentionally gave people a cold, the effect vanishes.
"The more rigorously scientific studies, where you took a group of people and gave half of them zinc and half a placebo and inoculated their nose with a cold virus, found there were no differences," said Terence Davidson, director of the UC San Diego Nasal Dysfunction Clinic in a February interview.
None of this stops ProPhase (NasdaqGM: PRPH), maker of ColdEeze zinc products, from making this claim on their website:
"Cold-EEZE® has been clinically proven to shorten the duration of the common cold by nearly half."  
As evidence, their website points to three studies from 10-20 years ago.  They conveniently ignore the more recent studies that showed far less (possibly no) benefit.

The authors of the latest review article graded the quality of evidence for five different outcomes.  Their report card on these studies has one "Moderate" and four "Low" grades.  Moderate means "further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.  Most of the grades were "low," which means
"further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate."  
So the authors themselves don't really trust their own study!  In the end, they conclude that "there is only a weak rationale" to recommend zinc.  And previous studies, not funded by supplement manufacturers, showed no benefit.  Who are you going to believe?

Save your money and use it to buy chicken soup instead.*

*The author receives no financial backing from the makers of chicken soup, although he does like it and would appreciate a free sample.

Got cold. Try zinc?


Having a cold is no fun.  Sore throat, runny nose, general feeling of all-around blechiness.  About the only good thing I can say about colds is that they don't last long, usually about a week.

We still don't have a cure for the common cold, but it's not for lack of trying.  For decades, Nobel laureate Linus Pauling promoted mega-doses of vitamin C as a way to prevent colds, but he turned out to be wrong on that one.  Somewhere in the neighborhood of 200 different viruses cause us to get colds, and we don't seem to be able to get rid of any of them.

In recent years, the most popular new remedy is zinc, usually in the form of a lozenge.  The evidence for zinc's effectiveness is not entirely clear, but a review published just last month, which looked at 13 different studies, concluded that zinc seems to help, just a little bit.  All 13 studies were randomized controlled trials, the gold standard of research, and collectively they included 966 people.

That sounds encouraging, but the benefit was disappointingly small: zinc seemed to shorten the duration of a cold by about one day.  So instead of being sick for 7 days, you might be sick for 6 days.

Or maybe not: Dr. Terence Davidson from UC San Diego argues that if you look at just the more rigorous studies, the effect vanishes entirely.

Chunks of elemental zinc
Then there are the worrisome reports that Zicam, a zinc-based cold remedy, causes people to lose their sense of smell.  (This may not sound so terrible, but some people reported a permanent loss.  Imagine never being able to smell fresh-baked bread again.)  In 2009, these reports led the FDA to issue a warning advising consumers to stop using three particular Zicam products.  In addition to over 130 reports directly to the FDA, Zicam's manufacturer had over 800 additional complaints about loss of sense of smell.

In an ironic twist, Zicam markets its products as homeopathic remedies, which means that the FDA cannot regulate them. It also means that they shouldn't contain any active ingredients, because homeopathic preparations are diluted until they contain nothing at all.  But Zicam does contain zinc, quite a lot of it, and the FDA's warning letter demanded that Zicam stop marketing these products because they had never demonstrated that they were safe and effective.

Zicam markets a wide range of zinc-containing products, and the FDA's warning only affected three of them.  Zicam's website today states that "there is no valid, scientific evidence showing a link between Zicam and anosmia [loss of sense of smell]."  Strictly speaking, this is correct, but there have been published reports suggesting a link, such as this one from 2006 and this one from 2009.  These studies looked at nasal sprays, not lozenges, suggesting that the risk (if any) comes from spraying the zinc product directly up your nose.

Aside: Zicam also claims that their products cure allergies too, for which there is not a shred of evidence.  Their website makes the sweeping claim that "all Zicam products are both effective and safe when taken as directed." I see no reason to trust these guys.

Conclusion: I'm not taking zinc.  The side effects might be minimal, but the benefit is very small and possibly zero.  I'll stick with hot tea, which at least makes my throat feel better.  Or chicken soup.  That can cure almost anything.